PharmaCyte Biotech, Inc.

NASDAQ:PMCB

1.56 (USD) • At close December 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Operating Activities:
Net Income 0.334-4.316-4.239-3.551-3.827-4.067-6.829-4.444-6.064-10.855-27.254-1.598-1.899-1.398-5.992-6.042-3.792-3.614-9.385-4.277-1.725-0.032-0.03-7.043
Depreciation & Amortization 00000000000-0.0060.0250.0410.1150.0290.0060.00100.0230000.027
Deferred Income Tax 000000000000000000000000
Stock Based Compensation 0.0010.6450.0780.3710.7480.7061.5251.0182.0996.2040.0180.001000000000000
Change In Working Capital 0.299-0.2970.009-0.1460.2670.167-0.086-0.021-0.8731.741-0.4920.3650.2390.1660.9314.748-2.731.031-4.1890.356-0.045-0.0050.0080
Accounts Receivables 000000000000.003-0.007-0.0010.1450.22300000000.223
Inventory 000000000000.0070.012-0.0160.1150.172-0.243000.047-0.047000.172
Accounts Payables 0.261-0.2430.033-0.0140.064-0.231-0.0130.03-0.1610.309-0.0590.0980.1740.0310.465-0.2990000000-0.299
Other Working Capital 0.0380.243-0.024-0.1320.2030.398-0.073-0.051-0.7131.433-0.4330.2570.060.1520.2064.651-2.4871.031-4.1890.3090.002-0.0050.0080
Other Non Cash Items -2.7850.1740.035-0.0050.4730.3170.310.1080.492-1.65126.1830.8491.3770.9663.9720.0795.3252.2312.5011.11.549005.831
Operating Cash Flow -2.151-3.794-4.117-3.331-2.338-2.878-5.079-3.339-4.346-4.56-1.563-0.39-0.259-0.225-0.974-1.185-1.191-0.352-1.072-2.798-0.221-0.037-0.022-1.185
Investing Activities:
Investments In Property Plant And Equipment 0000000000-3.50000-0.005-0.021-0.697-0.007-0.071-0.04500-0.005
Acquisitions Net 0000000000-0.051-0.647-0.874000.008000.00100000
Purchases Of Investments 000000000000000.025-0.03100-0.001-0.51000-0.031
Sales Maturities Of Investments 000000000000000.075-0.031000.1660.350000
Other Investing Activites -5000000000-0.004-0.0010.0030-0.0250.0460.0110.003-0.00200000.023
Investing Cash Flow -5000000000-3.551-0.647-0.87200.075-0.014-0.01-0.6940.158-0.231-0.04500-0.014
Financing Activities:
Debt Repayment 00000.0630000-0.1440.020.0751.0690.117-0.2090.039001.0952.9830.325000
Common Stock Issued 0087.3624.6992.6632.3432.6814.8823.5683.7868.5111.1460.0210.1640.5050.251.4851.0860.8500000.252
Common Stock Repurchased -44.358-13.56100-00000000000000000000
Dividends Paid 00000000000000-0.02000000000
Other Financing Activities 17.490.001-0.051-0.06200000000000.0200.1210000.0250.0370.0220.289
Financing Cash Flow -10.708-13.5687.3114.6372.7262.3432.6814.8823.5683.6428.5311.2211.090.2820.2960.2891.6051.0861.9452.9830.350.0370.0220.289
Other Information:
Effect Of Forex Changes On Cash -0.001-0.0070.0050.001-0.008-0.009-0.0060.001-0.0010.00100000000000.266000
Net Change In Cash -0.018-17.36183.1991.3070.38-0.545-2.4041.543-0.779-0.9173.4170.184-0.0410.056-0.603-0.910.4040.041.031-0.0450.3500-0.91
Cash At End Of Period 50.1868.0485.4012.2020.8950.5151.063.4641.9212.73.6160.1990.0160.0570.0010.6041.5141.1091.0690.0380.084000.604